Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P100
Near historical high
vs 2Y Ago
3.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 181.52% |
| Q3 2025 | -5.34% |
| Q2 2025 | -13.13% |
| Q1 2025 | -9.80% |
| Q4 2024 | 83.41% |
| Q3 2024 | 142.84% |
| Q2 2024 | -22.58% |
| Q1 2024 | -15.82% |
| Q4 2023 | 58.09% |
| Q3 2023 | -19.25% |
| Q2 2023 | -14.58% |
| Q1 2023 | 7.52% |
| Q4 2022 | -7.11% |
| Q3 2022 | -7.13% |
| Q2 2022 | -10.56% |
| Q1 2022 | 57.08% |
| Q4 2021 | -4.11% |
| Q3 2021 | 7.94% |
| Q2 2021 | -8.30% |
| Q1 2021 | 25.78% |
| Q4 2020 | -4.33% |
| Q3 2020 | -2.53% |
| Q2 2020 | 159.73% |
| Q1 2020 | 28.61% |
| Q4 2019 | 40.55% |
| Q3 2019 | 8.22% |
| Q2 2019 | -15.21% |
| Q1 2019 | -6.81% |
| Q4 2018 | -24.41% |
| Q3 2018 | -14.62% |
| Q2 2018 | -6.90% |
| Q1 2018 | -5.44% |
| Q4 2017 | 3.04% |
| Q3 2017 | 11.08% |
| Q2 2017 | 1.07% |
| Q1 2017 | -24.96% |
| Q4 2016 | -23.39% |
| Q3 2016 | 76.16% |
| Q2 2016 | -18.21% |
| Q1 2016 | 5.70% |